255 related articles for article (PubMed ID: 37454245)
1. A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy.
Yang H; Sun Y; Wang P; Qiao J; Li L; Lu Z; Sun X; Zhang C; Chen X; Yan M; Cui S; Wang C; Liu Z
Med Sci Monit; 2023 Jul; 29():e940124. PubMed ID: 37454245
[TBL] [Abstract][Full Text] [Related]
2. Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?
Williams AD; Ruth K; Shaikh SS; Vasigh M; Pronovost MT; Aggon AA; Porpiglia AS; Bleicher RJ
Cancer; 2024 Apr; 130(7):1052-1060. PubMed ID: 38018862
[TBL] [Abstract][Full Text] [Related]
3. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
[TBL] [Abstract][Full Text] [Related]
5. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients with 1-2 positive sentinel lymph node macro-metastases: a retrospective analysis of two independent cohorts.
Yu Y; Wang Z; Wei Z; Yu B; Shen P; Yan Y; You W
BMC Cancer; 2021 Apr; 21(1):466. PubMed ID: 33902502
[TBL] [Abstract][Full Text] [Related]
7. Candidates of Genomic Tests in HR+/HER2- Breast Cancer Patients With 1-2 Positive Sentinel Lymph Node Without Axillary Lymph Node Dissection: Analysis From Multicentric Cohorts.
Bi Z; Chen JJ; Liu PC; Chen P; Wang WL; Liu YB; Wang CJ; Qiu PF; Lv Q; Wu J; Wang YS
Front Oncol; 2021; 11():722325. PubMed ID: 34422668
[TBL] [Abstract][Full Text] [Related]
8. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
[TBL] [Abstract][Full Text] [Related]
9. Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
Madekivi V; Boström P; Karlsson A; Aaltonen R; Salminen E
Acta Oncol; 2020 Jun; 59(6):689-695. PubMed ID: 32148141
[No Abstract] [Full Text] [Related]
10. A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1-2HR+ breast cancer.
Xiang K; Chen J; Min Y; Chen H; Yang J; Hu D; Han Y; Yin G; Feng Y
Front Endocrinol (Lausanne); 2023; 14():1121394. PubMed ID: 37476497
[TBL] [Abstract][Full Text] [Related]
11. Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery.
Ahn SK; Kim MK; Kim J; Lee E; Yoo TK; Lee HB; Kang YJ; Kim J; Moon HG; Chang JM; Cho N; Moon WK; Park IA; Noh DY; Han W
Cancer Res Treat; 2017 Oct; 49(4):1088-1096. PubMed ID: 28161935
[TBL] [Abstract][Full Text] [Related]
12. Nomogram models for stratified prediction of axillary lymph node metastasis in breast cancer patients (cN0).
Gao X; Luo W; He L; Yang L
Front Endocrinol (Lausanne); 2022; 13():967062. PubMed ID: 36111297
[TBL] [Abstract][Full Text] [Related]
13. Application of a predictive model of axillary lymph node status in patients with sentinel node metastasis from breast cancer. A retrospective cohort study.
Vieni S; Graceffa G; La Mendola R; Latteri S; Cordova A; Latteri MA; Cipolla C
Int J Surg; 2016 Nov; 35():58-63. PubMed ID: 27633450
[TBL] [Abstract][Full Text] [Related]
14. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes.
Yang Z; Lan X; Huang Z; Yang Y; Tang Y; Jing H; Wang J; Zhang J; Wang X; Gao J; Wang J; Xuan L; Fang Y; Ying J; Li Y; Huang X; Wang S
Breast; 2020 Oct; 53():143-151. PubMed ID: 32823167
[TBL] [Abstract][Full Text] [Related]
15. Predicting Non-sentinel Lymph Node Metastasis in a Chinese Breast Cancer Population with 1-2 Positive Sentinel Nodes: Development and Assessment of a New Predictive Nomogram.
Chen JY; Chen JJ; Xue JY; Chen Y; Liu GY; Han QX; Yang WT; Shen ZZ; Shao ZM; Wu J
World J Surg; 2015 Dec; 39(12):2919-27. PubMed ID: 26324157
[TBL] [Abstract][Full Text] [Related]
16. Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
Zheng J; Cai S; Song H; Wang Y; Han X; Wu H; Gao Z; Qiu F
Medicine (Baltimore); 2018 Nov; 97(44):e13015. PubMed ID: 30383658
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
[TBL] [Abstract][Full Text] [Related]
18. Nomogram Utilizing ABVS Radiomics and Clinical Factors for Predicting ≤ 3 Positive Axillary Lymph Nodes in HR+ /HER2- Breast Cancer with 1-2 Positive Sentinel Nodes.
Hu B; Xu Y; Gong H; Tang L; Wang L; Li H
Acad Radiol; 2024 Feb; ():. PubMed ID: 38383259
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
[TBL] [Abstract][Full Text] [Related]
20. Does ultrasound evaluation of the axilla increase the rate of axillary lymph node dissection in early stage clinically node negative breast cancer patients?
Vasigh M; Meshkati Yazd SM; Karoobi M; Hajebi R; Yazdankhah Kenari A
BMC Surg; 2022 Mar; 22(1):80. PubMed ID: 35241059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]